A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction

BJU International

Volumn 89, Issue 4, 2002, Pages 409-415

  Von Keitz, A T ^a   Stroberg P ^b   Bukofzer, S ^c   Mallard, N ^c   Hibberd, M ^c  

^a ED Kliniken ^*

^b ABBOTT LABORATORIES   (United States)

^c Takeda Europe R and D Centre   (United Kingdom)

Author keywords

Apomorphine; Erectile dysfunction; Forced dose escalation; Sublingual; Tolerability

Indexed keywords

APOMORPHINE; PLACEBO;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES INSIPIDUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; EUROPE; HEADACHE; HEMATOLOGY; HETEROSEXUALITY; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; NAUSEA; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RECORDING; RISK FACTOR; SAFETY; SCREENING TEST; SEXUAL INTERCOURSE; STANDARD; TABLET; VERTIGO;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUROPE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; TABLETS; TREATMENT OUTCOME;

EID: 0036223259     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.01453.x     Document Type: Article

References (18)

1. Impotence. NIH consensus development panel on impotence
2. The prevalence and perceived aetiology of male sexual problems in a non-clinical sample
3. Epidemiologia della disfunzione erettile in Italia
4. Sexual disabilities, problems and satisfaction in 18-740-year-old Swedes
5. The epidemiology of erectile dysfunction
6. Pharmacological treatment of erectile dysfunction
7. Oral non-endocrine treatment
8. Oral medications in the management of erectile dysfunction
9. Regulation of masculine sexual behaviour: Involvement of brain opioids and dopamine
10. Neuromodulation of penile erection: An overview of the role of neurotransmitters and neuropeptides
11. The characterization of a bio-assay of erectile function in a rat model
12. Central control of erection and its pharmacological modification
13. Apomorphine. An update of clinical trial results
14. Sensitisation and tolerance to apomorphine in men: Yawning, growth hormone, nausea and hyperthermia
15. Oral dopamine agonists adverse drug reaction profile
16. International Conference on harmonisation; Draft guidelines on statistical principles for clinical trials; Availability
17. Efficacy and safety of fixed dose and dose-optimisation regimens of sublingual apomorphine versus placebo in men with erectile dysfunction
18. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction